Reply.
Hirano, I; Collins, MH; Katzka, DA; Mukkada, VA; Falk, GW; Morey, R; Desai, NK; Lan, L; Williams, J; Dellon, ES.
Clinical Gastroenterology and Hepatology.
2022;
20:1189-1190.
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.
Shoda, T; Collins, MH; Rochman, M; Wen, T; Caldwell, JM; Mack, LE; Osswald, GA; Besse, JA; Haberman, Y; Aceves, SS; et al.
Gastroenterology.
2022;
162:1635-1649.
Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis.
Safroneeva, E; Pan, Z; King, E; Martin, LJ; Collins, MH; Yang, GY; Capocelli, KE; Arva, NC; Abonia, JP; Atkins, D; et al.
Clinical Gastroenterology and Hepatology.
2022;
20:766-775.e4.
Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission.
Ben-Baruch Morgenstern, N; Ballaban, AY; Wen, T; Shoda, T; Caldwell, JM; Kliewer, K; Felton, JM; Abonia, JP; Mukkada, VA; Putnam, PE; et al.
Journal of Allergy and Clinical Immunology.
2022.
Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial.
Hirano, I; Collins, MH; Katzka, DA; Mukkada, VA; Falk, GW; Morey, R; Desai, NK; Lan, L; Williams, J; Dellon, ES.
Clinical Gastroenterology and Hepatology.
2022;
20:525-534.e10.
Acquired Esophageal Strictures in Children: Morphometric and Immunohistochemical Analyses.
Collins, MH; Alexander, ES; Martin, LJ; Grotjan, TM; Mukkada, VA; Sheil, A; Abonia, JP; Putnam, PE; Rothenberg, ME.
Pediatric and Developmental Pathology.
2022;
25:124-133.
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort.
Hirano, I; Collins, MH; King, E; Sun, Q; Chehade, M; Abonia, JP; Bonis, PA; Capocelli, KE; Dellon, ES; Falk, GW; et al.
American Journal of Gastroenterology.
2022;
117:413-423.
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.
Dellon, ES; Gonsalves, N; Abonia, JP; Alexander, JA; Arva, NC; Atkins, D; Attwood, SE; Auth, MK H; Bailey, DD; Biederman, L; et al.
Clinical Gastroenterology and Hepatology.
2022.
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS).
Ma, C; Schoepfer, AM; Dellon, ES; Bredenoord, AJ; Chehade, M; Collins, MH; Feagan, BG; Furuta, GT; Gupta, SK; Hirano, I; et al.
Journal of Allergy and Clinical Immunology.
2022;
149:659-670.
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.
Shoda, T; Wen, T; Caldwell, JM; Ben-Baruch Morgenstern, N; Osswald, GA; Rochman, M; Mack, LE; Felton, JM; Abonia, JP; Arva, NC; et al.
Gastroenterology.
2022;
162:439-453.